Pharma news
Americas
Gilead has obtained exclusive worldwide rights to market a long-acting injectable HIV product based on Durect Corporation’s Saber technology. 24 July 2019
Americas
The US Food and Drug Administration last week approved nine applications for the first generic versions of Pfizer’s Lyrica. 24 July 2019
Pharma
The English High Court has ruled that a patent owned by Roche should be revoked on grounds of insufficiency. 23 July 2019
Americas
Ireland-headquartered Endo Pharmaceuticals agreed to pay $2.3 million to 18 states late last week, settling allegations that the drugmaker paid a competitor to keep a generic version of pain relief drug Lidoderm off the market. 22 July 2019
Americas
Eversheds Sutherland has continued its expansion in the US, with the opening of a San Diego office and the addition of three IP litigators. 22 July 2019
Asia
Hong Kong customs authorities have carried out a series of raids resulting in the seizure of counterfeit vaccines worth over HKD $1 million, some containing poison. 18 July 2019
Pharma
Johnson & Johnson has warned that strong competition from generic drugs could impact the company’s figures for the rest of the year. 18 July 2019
Pharma
India’s Delhi High Court has dismissed a petition for an injunction by German pharma company Bayer against an Indian competitor. 18 July 2019
Pharma
Gilead will pay more than $5 billion as part of a collaborative research and development agreement with Belgian-Dutch pharmaceutical company Galapagos. 16 July 2019
Pharma
The US Court of Appeals for the Federal Circuit has upheld an earlier ruling that Indivior cannot stop two competitors from making a generic version of one of its drugs. 15 July 2019